Doximity (DOCS)
(Delayed Data from NYSE)
$27.50 USD
+0.41 (1.51%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $27.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$27.50 USD
+0.41 (1.51%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $27.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Zacks News
5 Large-Cap Stocks Likely to Win Big on Earnings Next Week
by Nalak Das
Five large-cap (market capital > $10 billion) stocks will report earnings results next week. These are: DHI, RNG, DOCS, DIS and AFRM.
What's in the Cards for Doximity (DOCS) in Q2 Earnings?
by Zacks Equity Research
Doximity's (DOCS) products like Doximity Dialer and Residency Navigator have been in focus and we expect both to have generated significant revenues during the fiscal second quarter.
DiDi Global (DIDI) Goes Public: Here's What You Need to Know
by Maharathi Basu
DiDi Global (DIDI) is currently trading at 17.1% above its IPO price.